The last few years for the publicly-traded stem cell clinic biz, US Stem Cell, Inc., which goes by the ticker $USRM, have seemed like a rollercoaster to me as an observer. I can see four main areas of news that to me make the future seem uncertain for this firm. First, the US Stem was linked to the […]
Clinic biz US Stem Cell reports SEC subpoena, adding to uncertainty on its future Read More »
Does a new lawsuit including Cell Surgical Network and its leadership as defendants pose a broad test to this entire chain of stem cell clinics, which may be the largest such affiliated clinic group in the U.S. and potentially even in the world? Will lawsuits substantially impact stem cell clinics? Lawsuits against unproven, for-profit stem cell
New lawsuit includes big stem cell clinic chain, Cell Surgical Network Read More »
Early in 2016, we started hearing about patient allegations of having been blinded in Florida by at least one stem cell business and several allegations seemed linked to a publicly-traded company called U.S. Stem Cell, Inc. (USRM). In turn, there have been a number of lawsuits involving USRM, including one filed just a few months
Sen. Grassley asks tough questions for FDA on U.S. Stem Cell, blinded women Read More »
I get asked many questions about stem cell therapies, but one of the most common over the years has been about the stem cell treatment cost. For instance, a reporter might ask, “How much does a stem cell treatment for MS cost?” and a patient might ask me, “How much is a fair cost for
Update on stem cell treatment cost for 2018 from ongoing poll Read More »
Can we humans grow healthy new brain cells as adults and during later aging? The answer to this question is a big deal because it could have major impact on aging. Those hoped-for new brain cells could keep our brains functionally younger. Who doesn’t want to slow down the aging of their brain, right? Slowing
Aging: can we grow new brain cells as adults? Read More »
Do stem cells for vision loss offer real hope? I believe so, but it’s a long road and must be done right. A new paper in this area generated some buzz on top of an earlier recent pub (mentioned in this post) just a week or so ago about the potential of stem cells for vision
Perspectives on new stem cells for vision loss paper Read More »
If you want to fight aging, should you turn to stem cells? Does the idea of stem cells to battle getting old even make any sense? The answer is, “it depends.” It’s a really interesting area conceptually and technically for stem cells. A theory. There is evidence that things that happen to our endogenous stem
Can stem cells really fight aging & if so, how? Read More »
Multiple sclerosis (MS) can be an extremely debilitating disease that ultimately is fatal in some patients and reduces life expectancy and quality overall substantially. An MS patient named Caroline Wyatt, who works at the BBC, had the courage to open up in full detail on the BBC about having MS, her experience getting an experimental
Patient’s Powerful Story on Multiple sclerosis and Getting Experimental Stem Cells Read More »
Today’s piece is a stem cell movers and shakers post about individuals who have gotten awards, made moves, or otherwise made news recently. In some cases I’ve included relevant embedded tweets announcing the news. In case you’re wondering, the image at right is my attempt last year to make a graphic design that reflect both
Stem cell movers and shakers early 2018 Read More »
There’s some recent stem cell good news out there including new papers and biotech developments. The stem cell and regenerative medicine field is really diverse and runs the gamut from really worrying stuff to very exciting, legit developments. In this post, I’m going to focus on the encouraging recent developments. What do I see as
Stem cell good news on biotechs & cool new organoid paper Read More »